Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration
ID: SPE2DP-25-R-0001Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/026199c994f943b7b96d61ec939bf413/view
Timeline
    Description

    The Defense Logistics Agency (DLA) Troop Support is seeking sources capable of providing live, oral, enteric-coated tablets of the Adenovirus Type 4 and Type 7 Vaccine for active immunization against respiratory infections. The procurement involves an Indefinite Delivery-Indefinite Quantity (IDIQ) contract with an estimated annual order quantity of 2,000 packages, each containing 100 doses of both vaccine types, with the first deliveries expected 3-6 months post-award. This vaccine is critical for military personnel health, and interested manufacturers must have FDA approval and provide detailed information regarding their production capabilities and product specifications. Responses to this Request for Information (RFI) should be submitted electronically to Yu Chen at yu.chen@dla.mil, as there is no solicitation at this time.

    Point(s) of Contact
    Yu Chen
    (215) 737-2103
    yu.chen@dla.mil
    Files
    No associated files provided.
    Similar Opportunities
    Dimethyl Fumarate DR Presolicitation
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    REQUEST FOR INFORMATION (RFI) FOR MARKET RESEARCH FOR THE MEDICAL/SURGICAL PRIME VENDOR PROGRAM - DLA TROOP SUPPORT
    Buyer not available
    The Defense Logistics Agency (DLA) is conducting a Request for Information (RFI) to gather market research for the Medical Surgical Prime Vendor Program (Med/Surg PV), aimed at developing an acquisition strategy for a long-term, indefinite quantity contract. This initiative is critical for providing a comprehensive range of medical and surgical supplies to designated Medical Treatment Facilities (MTFs) through a single distribution channel, ensuring next-day delivery of both brand name and generic products. Interested vendors are invited to respond to the RFI by February 28, 2025, with submissions directed to Beatrice Lopez-Pollard, Contracting Officer, via mail or email at beatrice.lopez-pollard@dla.mil. The information collected will inform the contract formation process while safeguarding proprietary submissions.
    Lansoprazole Capsules
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Lansoprazole capsules, specifically 30MG in 100 count bottles. This procurement aims to establish a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons, ensuring a reliable supply of this essential pharmaceutical item. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, with the solicitation expected to be posted in April 2024. Interested parties should direct inquiries to Jeremy Brown at jeremy.brown@dla.mil or 215-737-6031, and are encouraged to set up automated notifications for updates on the solicitation through the DLA Bid Board System and Sam.Gov.
    Doxycycline Hyclate
    Buyer not available
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Doxycycline Hyclate. The contract will establish a national supply source to provide Doxycycline Hyclate 100MG Tablets in various bottle sizes. This acquisition is for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be firm-fixed price, requirements type with a one year base and four one year options. Interested parties should contact Catherine Gilbert for more information. The projected solicitation date is September 2019.
    43--FILTER ASSEMBLY,FLU
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA Land and Maritime), is seeking quotes for the procurement of 17 units of the Filter Assembly, Flu (NSN 4330014826052). This solicitation aims to establish an Indefinite Delivery Contract (IDC) with a one-year term, allowing for a maximum aggregate order total of $250,000, with an estimated three orders per year and a guaranteed minimum quantity of two. The items will be shipped to various DLA depots both within the continental United States (CONUS) and outside (OCONUS), highlighting the importance of these components in supporting military operations. Interested vendors must submit their quotes electronically, and any inquiries should be directed to the buyer via email at DibbsBSM@dla.mil, with the solicitation available on the DLA's DIBBS website.
    43--FILTER ASSEMBLY,FLU
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA Land and Maritime), is seeking quotes for the procurement of 42 units of the Filter Assembly, Flu (NSN 4330016173922). This solicitation aims to establish an Indefinite Delivery Contract (IDC) for the specified item, which is crucial for various applications within military operations. The contract will have a term of one year or until the total orders reach $250,000, with an estimated 12 orders per year and a guaranteed minimum quantity of 6. Interested vendors must submit their quotes electronically, and any inquiries should be directed to the buyer via email at DibbsBSM@dla.mil. The solicitation is available online, and hard copies will not be provided.
    Request for Information (RFI) for Fresh Milk & Dairy Products support for DLA Troop Support to military customers in the state of Virginia (Fort Eustis, Fort AP Hill, Fort Gregg Adams and Langley AFB customers).
    Buyer not available
    The Defense Logistics Agency (DLA) Troop Support is seeking information from suppliers regarding the provision of fresh milk and dairy products to military customers in Virginia, specifically at Fort Eustis, Fort AP Hill, Fort Gregg Adams, and Langley Air Force Base. The agency intends to establish an indefinite quantity contract to ensure timely delivery of high-quality dairy products, emphasizing the need for same-day delivery capabilities for emergency orders and adherence to strict food safety standards. This procurement is critical for supporting the nutritional needs of military personnel stationed at these installations, with a contract period from July 20, 2025, to July 15, 2028, and a maximum value of $5,690,532.23. Interested vendors are encouraged to respond to the attached questionnaire by February 10, 2025, and may contact Katie Ann Wimsey or James Barr via email for further information.
    Telmisartan Tablets
    Buyer not available
    The Defense Logistics Agency (DLA) is soliciting proposals for the procurement of Telmisartan Tablets, a pharmaceutical product, to be delivered over multiple contract years. This solicitation, identified as SPE2D2-24-R-0015, requires compliance with various federal regulations, including the submission of a Subcontracting Plan for large businesses and adherence to Federal Acquisition Regulation (FAR) clauses concerning ethics and subcontracting practices. Telmisartan is crucial for managing hypertension and ensuring a reliable pharmaceutical supply is vital for military personnel's health. Interested vendors should submit their electronic proposals via the Defense Logistics Agency Internet Bid Board System (DIBBS) and can contact Courtney Hunter-Stangler at 215-737-6845 or via email at Courtney.Hunter-Stangler@dla.mil for further information.
    Specimen Container Peel Pack
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Famotidine
    Buyer not available
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Famotidine, a drug used to treat ulcers and gastroesophageal reflux disease (GERD). The contract will include Famotidine 20 MG tablets in various bottle sizes and Famotidine 40 MG tablets in different bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The annual usage estimates will be provided in the solicitation. The solicitation is expected to be posted on the DLA Bid Board System (DIBBS) and SAM.gov. For any questions or comments, interested parties should contact Kristen Baraniewicz. The projected solicitation date is August 2022, but DLA reserves the right to issue the solicitation before or after that date.